Dexlansoprazole (DrugBank: Dexlansoprazole)
7 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
63 | 特発性血小板減少性紫斑病 | 0 |
71 | 特発性大腿骨頭壊死症 | 0 |
85 | 特発性間質性肺炎 | 0 |
98 | 好酸球性消化管疾患 | 1 |
166 | 弾性線維性仮性黄色腫 | 0 |
222 | 一次性ネフローゼ症候群 | 0 |
299 | 嚢胞性線維症 | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01479231 (ClinicalTrials.gov) | March 2012 | 22/11/2011 | Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis | Predictors of PPI Response in Eosinophilic Esophagitis | Gastroesophageal Reflux Disease;Eosinophilic Esophagitis;Dysphagia | Drug: dexlansoprazole | Mayo Clinic | NULL | Withdrawn | 18 Years | 80 Years | Both | 0 | Phase 1;Phase 2 | United States |